CUNY SPH weekly COVID-19 survey update week 10
Global study to test malaria drug to protect health workers from COVID-19
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
Billionaire Ray Dalio Snatches up These 3 “Strong Buy” Stocks
Bob Langer-founded cell therapy player loads up $65M to fund Roche-partnered cancer work while expanding into vaccines for infectious diseases
Weekly data preview: more stimulus in view from the Fed
Microsoft, UnitedHealth Launch Back-to-Work Covid-19 Screening App
We Could Face The Darkest Winter In Modern History As Coronavirus Death Toll, Unemployment Soar
Scientists collaborate to create new physics-based technology for COVID-19 detection
2 "Strong Buy" 5G Stocks to Snap Up (And 1 to Avoid)
Analyst Places a Long-Shot Bet on Pluristem (PSTI) Stock
Applied DNA Sciences Tackles COVID-19 on Three Fronts; Analyst Says 'Buy'
Detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine
2 5G Stocks to Snap Up (And 1 to Avoid)
Skilled partners in the conduct of HIV prevention trials join COVID-19 response
COVID-19 Implications: Updated Thinking
COVID-19: William Blair’s Proactive Response
COVID-19: Stress Testing
COVID-19: Science and Economics
The US to waste coronavirus stimulus money on fossil fuels
Biotech’s Golden Moment
Alberta researchers, Tonix Pharmaceuticals race to develop candidate vaccines for COVID-19
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
Coronavirus dashboard: updating the 52 Petri Dishes of democracy
Morgan Stanley: 2 Stocks That Could Surge Over 25%
Covid-19 roundup: Gilead selects 5 generic manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
Will Powell have any more Luck Pushing against Negative Rate Expectations in the US?
Merck CPO Julie Gerberding On The Deadliness Of Covid-19
CEO Albert Bourla On Pfizer’s Involvement With Covid-19
Epic CEO Judy Faulkner on developing new therapies for COVID-19